PAP Vaccine (Madison Vaccines)

N/A

Report date: 2026/03/07 20:00:27

Base Information

Drug NamePAP Vaccine (Madison Vaccines)
Drug Alias NamepTVG-HPMVI-816
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsNeoplasm MetastasisProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMadison Vaccines Inc
China Registration ClassN/A

Develop Information

Active CompaniesMadison Vaccines IncUniversity Of Wisconsin-Madison
Inactive CompaniesN/A
Active IndicationsNeoplasm MetastasisProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A